Bayer Aktiengesellschaft (BAYZF.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec17

Bayer's BlueRock Cell Therapy Designated as Pioneer Regenerative Medical Product in Japan

07:33

Dec10

HSBC Raises Bayer's Price Target to 40 Euros

06:19

Dec8

JPMorgan Raises Bayer's Rating to Overweight

04:07

Dec3

Bayer to launch new soybean seed resistant to five herbicides in Brazil

23:38

Morgan Stanley Raises Bayer Target Price to 40 Euros

07:03

Morgan Stanley Upgrades Bayer Stock Rating

06:37

Schedules & Filings

Schedules

Filings

Nov11

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.33 B, Net Income -1.129 B, EPS -1.1495

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 12.57 B, Net Income -232.94 M, EPS -0.2371

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.87 B, Net Income 1.406 B, EPS 1.4288

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More